Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
04 05 2020
Historique:
entrez: 5 5 2020
pubmed: 5 5 2020
medline: 8 5 2020
Statut: epublish

Résumé

The reproductive number in Switzerland was between 1.5 and 2 during the first third of March, and has consistently decreased to around 1. After the announcement of the latest strict measure on 20 March 2020, namely that gatherings of more than five people in public spaces are prohibited, the reproductive number dropped significantly below 1; the authors of this study estimate the reproductive number to be between 0.6 and 0.8 in the first third of April.

Identifiants

pubmed: 32365217
doi: 10.4414/smw.2020.20271
pii: Swiss Med Wkly. 2020;150:w20271
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20271

Auteurs

Jeremie Scire (J)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Sarah Nadeau (S)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Timothy Vaughan (T)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Gavin Brupbacher (G)

Department of Sport, Exercise and Health, University of Basel, Switzerland.

Simon Fuchs (S)

Department of Health, Canton of Basel-Stadt, Switzerland.

Jürg Sommer (J)

Cantonal Office of Public Health, Economics and Health Directorate, Canton of Basel-Landschaft, Switzerland.

Katrin N Koch (KN)

Cantonal Office of Public Health, Economics and Health Directorate, Canton of Basel-Landschaft, Switzerland.

Reto Misteli (R)

Canton Basel-Land Medical Association, Switzerland.

Lukas Mundorff (L)

Canton Basel-Land Medical Association, Switzerland.

Thomas Götz (T)

Canton Basel-Land Medical Association, Switzerland.

Tobias Eichenberger (T)

Canton Basel-Land Medical Association, Switzerland.

Carlos Quinto (C)

Schweizerisches Tropen- und Public Health Institut, Universität Basel, Switzerland / Universitäres Zentrum für Hausarztmedizin beider Basel, Universität Basel, Switzerland.

Miodrag Savic (M)

Cantonal Office of Public Health, Economics and Health Directorate, Canton of Basel-Landschaft, Switzerland / Department of Surgery, Clinic of Oral- and Cranio-Maxillofacial Surgery, University Hospital Basel, Switzerland.

Andrea Meienberg (A)

University Hospital Basel, Switzerland.

Thilo Burkard (T)

University Hospital Basel, Switzerland.

Michael Mayr (M)

University Hospital Basel, Switzerland.

Christoph A Meier (CA)

University Hospital Basel, Switzerland.

Andreas Widmer (A)

University Hospital Basel, Switzerland.

Richard Kuehl (R)

University Hospital Basel, Switzerland.

Adrian Egli (A)

University Hospital Basel, Switzerland.

Hans H Hirsch (HH)

University Hospital Basel, Switzerland / University of Basel, Switzerland.

Stefano Bassetti (S)

University Hospital Basel, Switzerland / University of Basel, Switzerland.

Christian H Nickel (CH)

University Hospital Basel, Switzerland.

Katharina S Rentsch (KS)

University Hospital Basel, Switzerland / Laboratory Medicine, University Hospital Basel, Switzerland.

Werner Kübler (W)

University Hospital Basel, Switzerland.

Roland Bingisser (R)

University Hospital Basel, Switzerland.

Manuel Battegay (M)

University Hospital Basel, Switzerland / University of Basel, Switzerland.

Sarah Tschudin-Sutter (S)

University Hospital Basel, Switzerland / University of Basel, Switzerland.

Tanja Stadler (T)

Department of Biosystems Science and Engineering, ETH Zürich, Switzerland / Swiss Institute of Bioinformatics, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH